企業プロフィール
Takeda 株価・ニュース・カタリスト
- ティッカー:
- TAK
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- Japan and listed in the U
株価パフォーマンス
17.38 USD (-1.42%)
終値
最終更新: 2026年8月17日
48B USD
時価総額
株価変動の要因
As of Aug 17, 2026, TAK closed down 1.42% at $17.38. No new same-company headline was identified in the current news window.
企業概要
事業概要
Takeda is a global pharmaceutical company with broad exposure to gastroenterology, oncology, rare disease, plasma-derived therapies, and vaccines. Its business is defined by scale, diversification, and a strong international footprint.
所在地とセクター分類
Takeda is headquartered in Japan and listed in the U.S. market. It sits in global large-cap pharma rather than biotech.
ビジネスモデルの特徴
The company generates value through branded medicines, portfolio diversification, and disciplined R&D reinvestment. Investors watch pipeline progress, earnings stability, and geographic breadth.
バイオ業界での位置付け
Takeda sits in the top tier of global pharma. It is less binary than biotech, but its pipeline and launch cadence still matter to the market.
今後のカタリスト
- Takeda’s catalysts are oncology, rare disease, and GI portfolio execution, plus any pipeline update that helps the growth mix evolve. The company will be watched for broad commercial stability.
最近のニュース
- 01
- 02
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。